APLS
Apellis Pharmaceuticals, Inc.Healthcare$40.41
▲ Bullish
Mkt Cap: $5.17B|Float: 83.2M|SI: 27.5%|DTC: 11.4
Data as of market close Apr 2, 2026
IV Rank
42
IV Pctl
44%
HV 20d
30690.0%
52W Range
$16-$40
ATR(14)
$2.24
Exp. Move
±0.8%
P/C Ratio
0.58
Earnings
May 7
GEX Positive
DEX Long
Net Call Premium
IV Moderate
Max Pain Below
Exp. Move Narrow
Low Put/Call
APLS Key Options Data
- IV Rank
- 42.3%
- Total GEX
- $0.01B
- Total DEX
- $1.2M
- Max Pain
- $20.00
- Expected Move
- ±0.8%
- Put/Call OI
- 0.58
- Net Premium
- $8.7M
- Spot Price
- $40.41
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$0.33 | ±0.8% | $40.08 | $40.73 |
| 2026-05-15 | 43 | ±$16.55 | ±41.0% | $23.86 | $56.96 |
| 2026-07-17 | 106 | ±$5.70 | ±14.1% | $34.71 | $46.11 |
| 2026-10-16 | 197 | ±$10.65 | ±26.4% | $29.76 | $51.06 |
| 2027-01-15 | 288 | ±$1.85 | ±4.6% | $38.56 | $42.26 |
Explore APLS options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.